MAP kinases differentially regulate the expression of macrophage hyperactivity after thermal injury

Journal of Cellular Physiology

Volumn 201, Issue 1, 2004, Pages 35-44

  Alexander, Michelle ^a   Daniel, Tanjanika ^a   Chaudry, Irshad H ^a   Schwacha, Martin G ^a  

^a Kentucky   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PROSTAGLANDIN E2; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BURN; CELL ACTIVITY; CELL HYPERACTIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; FEMALE; IMMUNE DEFICIENCY; INFLAMMATION; MACROPHAGE; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SEPSIS; SIGNAL TRANSDUCTION; SPLEEN CELL; THERMAL INJURY;

ANIMALS; ANTHRACENES; BURNS; ENZYME INHIBITORS; FEMALE; FLAVONOIDS; IMIDAZOLES; IMMUNOPHENOTYPING; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIPOPOLYSACCHARIDES; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4444355609     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20050     Document Type: Article

References (88)

1. Abraham E. 2003. Nuclear factor-kappaB and its role in sepsis-associated organ failure. J Infect Dis 187(Suppl 2):S364-S369.
2. Ajizian SJ, English BK, Meals EA. 1999. Specific inhibitors of p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma. J Infect Dis 179: 939-944.
3. Alexander M, Chaudry IH, Schwacha MG. 2002. Relationships between burn size, immunosuppression, and macrophage hyperactivity in a murine model of thermal injury. Cell Immunol 220: 63-69.
4. Arbabi S, Maier RV. 2002. Mitogen-activated protein kinases. Crit Care Med 30:S74-S79.
5. Babcock TA, Kurland A, Helton WS, Rahman A, Anwar KN, Espat NJ. 2003. Inhibition of activator protein-1 transcription factor activation by omega-3 fatty acid modulation of mitogen-activated protein kinase signaling kinases. JPEN J Parenter Enteral Nutr 27:176-180.
6. Ballard-Croft C, Maass DL, Sikes P, White J, Horton J. 2002. Activation of stress-responsive pathways by the sympathetic nervous system in burn trauma. Shock 18:38-45.
7. Baue AE, Durham R, Faist E. 1998. Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): Are we winning the battle? Shock 10: 79-89.
8. Browning DD, Windes ND, Ye RD. 1999. Activation of p38 mitogen-activated protein kinase by lipopolysaccharide in human neutrophils requires nitric oxide-dependent cGMP accumulation. J Biol Chem 274:537-542.
9. Caamano J, Hunter CA. 2002. NF-kappaB family of transcription factors: Central regulators of innate and adaptive immune functions. Clin Microbiol Rev 15:414-429.
10. Carter Y, Liu G, Yang J, Fier A, Mendez C. 2003. Sublethal hemorrhage induces tolerance in animals exposed to cecal ligation and puncture by altering p38, p44/42, and SAPK/JNK MAP kinase activation. Surg Infect (Larchmt) 4:17-27.
11. Chae HJ, Kim SC, Chae SW, An NH, Kim HH, Lee ZH, Kim HR. 2001. Blockade of the p38 mitogen-activated protein kinase pathway inhibits inducible nitric oxide synthase and interleukin-6 expression in MC3T3E-1 osteoblasts. Pharmacol Res 43:275-283.
12. Chan ED, Riches DW. 1998. Potential role of the JNK/SAPK signal transduction pathway in the induction of iNOS by TNF-alpha. Biochem Biophys Res Commun 253:790-796.
13. Chan ED, Riches DW. 2001. IFN-gamma + LPS induction of iNOS is modulated by ERK, JNK/SAPK, and p38(mapk) in a mouse macrophage cell line. Am J Physiol Cell Physiol 280:C441-C450.
14. Chen P, Li J, Barnes J, Kokkonen GC, Lee JC, Liu Y. 2002. Restraint of proinflammatory cytokine biosynthesis by mitogen-activated protein kinase phosphatase-1 in lipopolysaccharide-stimulated macrophages. J Immunol 169:6408-6416.
15. Chen JX, Berry LC, Christman BW, Meyrick B. 2003. Glutathione mediates LPS-stimulated COX-2 expression via early transient p42/44 MAPK activation. J Cell Physiol 197:86-93.
16. Davis RJ. 2000. Signal transduction by the JNK group of MAP kinases. Cell 103:239-252.
17. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries J. 1991. Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: And autoregulatory role of IL-10 produced by monocytes. J Exp Med 174:1209-1220.
18. Deitch EA. 1992. Multiple organ failure: Pathophysiology and potential future therapy. Ann Surg 216:117-134.
19. Deora AA, Hajjar DP, Lander HM. 2000. Recruitment and activation of Raf-1 kinase by nitric oxide-activated Ras. Biochemistry 39: 9901-9908.
20. Downey JS, Han J. 1998. Cellular activation mechanisms in septic shock. Front Biosci 3:D468-D476.
21. English JM, Cobb MH. 2002. Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci 23:40-45.
22. Fang WH, Yao YM, Shi ZG, Yu Y, Wu Y, Lu LR, Sheng ZY. 2003. The mRNA expression patterns of tumor necrosis factor-alpha and TNFR-I in some vital organs after thermal injury. World J Gastroenterol 9:1038-1044.
23. 2+-mediated neutrophil O responses with thermal injury. Am J Physiol Cell Physiol 283: C1469-C1479.
24. Foey AD, Parry SL, Williams LM, Feldmann M, Foxwell BM, Brennan FM. 1998. Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: Role of the p38 and p42/44 mitogen-activated protein kinases. J Immunol 160:920-928.
25. Furuichi S, Hashimoto S, Gon Y, Matsumoto K, Horie T. 2002. p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase regulate interleukin-8 and RANTES production in hyperosmolarity stimulated human bronchial epithelial cells. Respirology 7:193-200.
26. Gamelli RL, George M, Sharp-Pucci M, Dries DJ, Radisazljevic Z. 1995. Burn-induced nitric oxide release in humans. J Trauma 39: 869-878.
27. Guha M, Mackman N. 2001. LPS induction of gene expression in human monocytes. Cell Signal 13:85-94.
28. Gupta S, Campbell D, Derijard B, Davis RJ. 1995. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science 267:389-393.
29. Hale KK, Trollinger D, Rihanek M, Manthey CL. 1999. Differential expression and activation of p38 mitogen-activated protein kinase alpha, beta, gamma, and delta in inflammatory cell lineages. J Immunol 162:4246-4252.
30. Hall JP, Davis RJ. 2002. Inhibition of the p38 pathway upregulates macrophage JNK and ERK activities, and the ERK, JNK, and p38 MAP kinase pathways are reprogrammed during differentiation of the murine myeloid M1 cell line. J Cell Biochem 86:1-11.
31. Hall JP, Merithew E, Davis RJ. 2000. c-Jun N-terminal kinase (JNK) repression during the inflammatory response? Just say NO. Proc Natl Acad Sci USA 97:14022-14024.
32. Hambleton J, Weinstein SL, Lem L, DeFranco AL. 1996. Activation of c-Jun N-terminal kinase in bacterial lipopolysaccharide-stimulated macrophages. Proc Natl Acad Sci USA 93:2774-2778.
33. Hempel L, Korholz D, Bonig H, Schneider M, Klein-Vehne A, Packeisen J, Mauz-Korholz C, Burdach S. 1995. Interleukin-10 directly inhibits the interleukin-6 production in T-cells. Scand J Immunol 41:462-466.
34. Hommes DW, Peppelenbosch MP, van Deventer SJ. 2003. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets. Gut 52:144-151.
35. Horgan AM, Stork PJ. 2003. Examining the mechanism of Erk nuclear translocation using green fluorescent protein. Exp Cell Res 285: 208-220.
36. Horton JW. 2003. Free radicals and lipid peroxidation mediated injury in burn trauma: The role of antioxidant therapy. Toxicology 189: 75-88.
37. Iles KE, Forman HJ. 2002. Macrophage signaling and respiratory burst. Immunol Res 26:95-105.
38. Janssen-Heininger YM, Macara I, Mossman BT. 1999. Cooperativity between oxidants and tumor necrosis factor in the activation of nuclear factor (NF)-kappaB: Requirement of Ras/mitogen-activated protein kinases in the activation of NF-kappaB by oxidants. Am J Respir Cell Mol Biol 20:942-952.
39. Jarrar D, Kuebler JF, Rue LW III, Matalon S, Wang P, Bland KI, Chaudry IH. 2002. Alveolar macrophage activation after trauma-hemorrhage and sepsis is dependent on NF-kappaB and MAPK/ERK mechanisms. Am J Physiol Lung Cell Mol Physiol 283:L799-L805.
40. Jiang JX, Zhang Y, Ji SH, Zhu P, Wang ZG. 2002. Kinetics of mitogen-activated protein kinase family in lipopolysaccharide-stimulated mouse Kupffer cells and their role in cytokine production. Shock 18:336-341.
41. Koprak S, Staruch MJ, Dumont FJ. 1999. A specific inhibitor of the p38 mitogen activated protein kinase affects differentially the production of various cytokines by activated human T cells: Dependence on CD28 signaling and preferential inhibition of IL-10 production. Cell Immunol 192:87-95.
42. Lightfoot EJ, Horton JW, Maass DL, White DJ, McFarland RD, Lipsky PE. 1999. Major burn trauma in rats promotes cardiac and gastrointestinal apoptosis. Shock 11:29-34.
43. Lo CJ. 2003. MAPK regulation of prostaglandin E2 production by lipopolysaccharide-stimulated macrophages is not dependent on nuclear factor kappaB. J Surg Res 113:189-194.
44. Lyons A, Kelly JL, Rodrick ML, Mannick JA, Lederer JA. 1997. Major injury induces increased production of interleukin-10 by cells of the immune system with a negative impact on resistance to infection. Ann Surg 226:450-458.
45. Ma W, Lim W, Gee K, Aucoin S, Nandan D, Kozlowski M, Diaz-Mitoma F, Kumar A. 2001. The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Spl transcription factor in lipopolysaccharide-stimulated human macrophages. J Biol Chem 276:13664-13674.
46. Masson I, Mathieu J, Nolland XB, Sousa MD, Chanaud B, Stralko S, Chancerelle Y, Kergonou JF, Giroud JP, Florentin I. 1998. Role of nitric oxide in depressed lymphproliferative responses and altered cytokine production following thermal injury in rats. Cell Immunol 186:121-132.
47. Maulik N, Sato M, Price BD, Das DK. 1998. An essential role of NFkappaB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemia. FEBS Lett 429: 365-369.
48. Meakins JL. 1990. Etiology of multiple organ failure. J Trauma 30: S165-S168.
49. Meyer CF, Wang X, Chang C, Templeton D, Tan TH. 1996. Interaction between c-Rel and the mitogen-activated protein kinase kinase kinase 1 signaling cascade in mediating kappaB enhancer activation. J Biol Chem 271:8971-8976.
50. Miller-Graziano CL, Fink M, Wu WY, Szabo G, Kodys K. 1988. Mechanisms of altered monocyte prostaglandin E2 production in severely injured patients. Arch Surg 123:293-299.
51. Molloy RG, O'Riordain M, Holtzeimer R, Nestor M, Collins K, Mannick JA, Rodrick ML. 1993. Mechanisms of increased tumor necrosis factor production after thermal injury. Altered sensitivity to PGE2 and immunomodulation by indomethacin. J Immunol 151: 2142-2149.
52. Muller JM, Ziegler-Heitbrock HW, Baeuerle PA. 1993. Nuclear factor kappa B, a mediator of lipopolysaccharide effects. Immunobiology 187:233-256.
53. Murr MM, Yang J, Fier A, Gallagher SF, Carter G, Gower WR, Jr., Norman JG. 2003. Regulation of Kupffer cell TNF gene expression during experimental acute pancreatitis: The role of p38-MAPK, ERK1/2, SAPK/JNK, and NF-kappaB. J Gastrointest Surg 7:20-25.
54. Nakayama K, Ota Y, Okugawa S, Ise N, Kitazawa T, Tsukada K, Kawada M, Yanagimoto S, Kimura S. 2003. Rafl plays a pivotal role in lipopolysaccharide- induced activation of dendritic cells. Biochem Biophys Res Commun 308:353-360.
55. Nake H, Endo S, Inada K, Yamashita H, Yamada Y, Taka T, Kasai T, Ogawa M, Uchida K. 1995. Plasma concentrations of type II phospholipase A2, cytokines, ecosinoids in patients with burns. Burns 21:422-426.
56. Nguyen TT, Gilpin DA, Meyer NA, Herndon DN. 1996. Current treatment of severely burned patients. Ann Surg 223:14-25.
57. Nishiura. T, Nishimura T, deSerres S, Godfrey V, Bradham CA, Nakagawa T, Brenner DA, Meyer AA. 2000. Gene expression and cytokine and enzyme activation in the liver after a burn injury. J Burn Care Rehabil 21:135-141.
58. O'Suilleabhain CB, Kim S, Rodrick MR, Mannick JA, Lederer JA. 2001. Injury induces alterations in T-cell NFkappaB and AP-1 activation. Shock 15:432-437.
59. Ogle CK, Mao JX, Wu JZ, Ogle JD, Alexander JW. 1994. The production of tumor necrosis factor, interleukin 1, interleukin 6, and prostaglandin E2 by isolated enterocytes and gut macrophages: Effect of lipopolysaccaride and thermal injury. J Burn Care Rehabil 15:470-477.
60. Okugawa S, Ota Y, Kitazawa T, Nakayama K, Yanagimoto S, Tsukada K, Kawada M, Kimura S. 2003. Janus kinase 2 is involved in lipopolysaccharide-induced activation of macrophages. Am J Physiol Cell Physiol 285:C399-C408.
61. Park HS, Huh SH, Kim MS, Lee SH, Choi EJ. 2000. Nitric oxide negatively regulates c-Jun N-terminal kinase/stress-activated protein kinase by means of S-nitrosylation. Proc Natl Acad Sci USA 97:14382-14387.
62. Perera PY, Mayadas TN, Takeuchi O, Akira S, Zaks-Zilberman M, Goyert SM, Vogel SN. 2001. CD11b/CD18 acts in concert with CD14 and toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression. J Immunol 166:574-581.
63. Prieser J, Reper P, Vlasselaer D, Vray B, Zang H, Metz G, Vanderlelen A, Vincient J. 1996. Nitric oxide production is increased in patients after burn injury. J Trauma 40:368-371.
64. Rao KM. 2001. MAP kinase activation in macrophages. J Leukoc Biol 69:3-10.
65. Rutault K, Hazzalin CA, Mahadevan LC. 2001. Combinations of ERK and p38 MAPK inhibitors ablate tumor necrosis factor-alpha (TNF-alpha) mRNA induction. Evidence for selective destabilization of TNF-alpha transcripts. J Biol Chem 276:6666-6674.
66. Saffle JR, Sullivan JJ, Tuohig GM, Larson CM. 1993. Multiple organ failure in patients with thermal injury. Crit Care Med 21:1673-1683.
67. Samy TS, Ayala A, Catania RA, Chaudry IH. 1998. Trauma-hemorrhage activates signal transduction pathways in mouse splenic T cells. Shock 9:443-450.
68. Schafer PH, Wadsworth SA, Wang L, Siekierka JJ. 1999. p38 alpha mitogen-activated protein kinase is activated by CD28-mediated signaling and is required for IL-4 production by human CD4+ CD45RO + T cells and Th2 effector cells. J Immunol 162:7110-7119.
69. Schorey JS, Cooper AM. 2003. Macrophage signalling upon mycobacterial infection: The MAP kinases lead the way. Cell Microbiol 5:133-142.
70. Schwacha MG. 2003. Macrophages and post-burn immune dysfunction. Burns 29:1-14.
71. Schwacha MG, Somers SD. 1998a. Thermal injury induced immunosuppression in mice: The role of macrophage derived reactive nitrogen intermediates. J Leuko Biol 63:51-58.
72. Schwacha MG, Somers SD. 1998b. Thermal injury induces macrophage hyperactivity through pretussis toxin-sensitive and -insensitive pathways. Shock 9:249-255.
73. Schwacha MG, Somers SD. 1999. Thermal injury induced enhancement of oxidative metabolism by mononuclear phagocytes. J Burn Care Rehabil 20:37-41.
74. Schwacha MG, Samy TSA, Cantania RA, Chaudry IH. 1998. Thermal injury alters macrophage responses to prostaglandin E2: Contribution to the enhancement of inducible nitric oxide synthase activity. J Leuko Biol 64:740-746.
75. Schwacha MG, Ayala A, Chaudry IH. 2000a. Insights into the role of gd T-lymphocytes in the immunopathogenic response to thermal injury. J Leuko Biol 67:644-650.
76. Schwacha MG, Knoferl MW, Chaudry IH. 2000b. Does burn wound excision after thermal injury attenuate subsequent macrophage hyperactivity and immunosuppression? Shock 14:623-628.
77. Schwacha MG, Schneider CP, Bland KI, Chaudry IH. 2001. Resistance of macrophages to the suppressive effect of interleukin-10 following thermal injury. Am J Physiol Cell Physiol 281:C1180-C1187.
78. Schwacha MG, Chung C-S, Ayala A, Bland KI, Chaudry IH. 2002. Cyclooxygenase-2-mediated suppression of macrophage interleukin-12 production following thermal injury. Am J Physiol Cell Physiol 282:C263-C270.
79. Schwacha MG, Chaudry IH, Alexander M. 2003. Regulation of macrophage IL-10 production postinjury via beta2 integrin signaling and the P38 MAP kinase pathway. Shock 20:529-535.
80. Seger R, Krebs EG. 1995. The MAPK signaling cascade. FASEB J 9:726-735.
81. Song GY, Chung CS, Jarrar D, Chaudry IH, Ayala A. 2001. Evolution of an immune suppressive macrophage phenotype as a product of P38 MAPK activation in polymicrobial sepsis. Shock 15:42-48.
82. Song GY, Chung CS, Jarrar D, Cioffi WG, Ayala A. 2002. Mechanism of immune dysfunction in sepsis: Inducible nitric oxide-meditated alterations in p38 MAPK activation. J Trauma 53:276-282.
83. Vogel S, Hirschfeld MJ, Perera PY. 2001. Signal integration in lipopolysaccharide (LPS)-stimulated murine macrophages. J Endotoxin Res 7:237-241.
84. Wang Z, Brecher P. 1999. Salicylate inhibition of extracellular signal-regulated kinases and inducible nitric oxide synthase. Hypertension 34:1259-1264.
85. Wang G, Tian J, Tang H, Zhu S, Huan J, Ge S, Xia Z. 2002. The role of Kupffer cells on the postburn production of TNFalpha, IL-1beta and IL-6 in severely scalded rats. Zhonghua Shao Shang Za Zhi 18:282-284.
86. Watters JJ, Sommer JA, Pfeiffer ZA, Prabhu U, Guerra AN, Bertics PJ. 2002. A differential role for the mitogen-activated protein kinases in lipopolysaccharide signaling: The MEK/ERK pathway is not essential for nitric oxide and interleukin 1beta production. J Biol Chem 277:9077-9087.
87. White JE, Lin HY, Davis FB, Davis PJ, Tsan MF. 2000. Differential induction of tumor necrosis factor alpha and manganese superoxide dismutase by endotoxin in human monocytes: Role of protein tyrosine kinase, mitogen-activated protein kinase, and nuclear factor kappaB. J Cell Physiol 182:381-389.
88. Zingarelli B, Sheehan M, Wong HR. 2003. Nuclear factor-kappaB as a therapeutic target in critical care medicine. Crit Care Med 31:S105-S111.